|131.25||-0.63 / -0.48%|
As of 3:59pm ET
|131.65||+0.40 / +0.30%|
The 20 analysts offering 12-month price forecasts for Celgene have a median target of 153.50, with a high estimate of 191.00 and a low estimate of 82.00. The median estimate represents a +16.95% increase from the last price of 131.25.
The current consensus among 23 polled investment analysts is to Buy stock in Celgene. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.